Tom Ermak

Tom received his Ph.D. in Marine Biology from the Scripps Institution of Oceanography at UCSD and later was a Postdoctoral Fellow and Research Cell Biologist at the UCSF School of Medicine for 12 years where he performed NIH sponsored research projects in Cell Structure, GI Cell Biology, and Mucosal Immunology. 

In 1992, Tom joined OraVax in Cambridge MA to develop oral vaccines and directed projects against GI infections, in particular Helicobacter pylori which was associated with gastric ulcers and stomach cancer  The company was later renamed Acambis, where Tom directed pre-clinical and clinical vaccine efficacy and mechanism of protection studies for submission to the FDA.  His studies contributed to the development of Acambis' vaccines against Smallpox, West Nile, Japanese Encephalitis, and Dengue Fever. Acambis is now the Boston centered US research center for Sanofi Pasteur vaccines in Lyon, France.

Email me at: